Cargando…

PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is considered a malignancy resulting from defects in apoptosis. For this reason, targeting apoptotic pathways in CLL may be valuable for its management. Poly [ADP-ribose] polymerase 1 (PARP1) is the main member of a family of nuclear enzymes that act as DNA damage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diamantopoulos, Panagiotis T., Sofotasiou, Maria, Papadopoulou, Vasiliki, Polonyfi, Katerina, Iliakis, Theodoros, Viniou, Nora-Athina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137605/ https://www.ncbi.nlm.nih.gov/pubmed/25161998 http://dx.doi.org/10.1155/2014/106713

Ejemplares similares

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2016)

PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2021)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2021)

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia
por: Iliakis, Theodoros, et al.
Publicado: (2014)

Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2020)

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
por: Chatzidavid, Sevastianos, et al.
Publicado: (2023)

An unusual case report of unilateral parotid gland sarcoidosis with spontaneous remission
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2019)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2022)

A case report of a very late response to 5-azacytidine in a patient with lower risk myelodysplastic syndrome: Time to update treatment guidelines for lower risk patients
por: Spetsieris, Nikolaos, et al.
Publicado: (2018)

Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of the literature
por: Spetsieris, Nikolaos, et al.
Publicado: (2018)

Deregulation of Autophagy and Apoptosis in Patients with Myelodysplastic Syndromes: Implications for Disease Development and Progression
por: Tsekoura, Georgia, et al.
Publicado: (2023)

A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis
por: Charakopoulos, Emmanouil, et al.
Publicado: (2020)

Bacillus Cereus in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022)

A Patient with Synchronous Gallbladder and Bone Plasmacytoma
por: Markouli, Mariam, et al.
Publicado: (2023)

Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations
por: Diamantopoulos, Panagiotis T, et al.
Publicado: (2012)

Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
por: Dimou, Maria, et al.
Publicado: (2021)

Apoptosis inducers in chronic lymphocytic leukemia
por: Billard, Christian
Publicado: (2013)

Are We Identifying Malnutrition in Hospitalized Patients with Hematologic Malignancies? Results from a Quality Clinical Audit
por: Kanioura, Eftychia, et al.
Publicado: (2022)

JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature
por: Chatzidavid, Sevastianos, et al.
Publicado: (2021)

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes
por: Diamantopoulos, P, et al.
Publicado: (2017)

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2014)

Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report
por: Bonou, Maria, et al.
Publicado: (2019)

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
por: Knittel, Gero, et al.
Publicado: (2017)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
por: Kotsianidis, Ioannis, et al.
Publicado: (2019)

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
por: Papageorgiou, Sotirios G., et al.
Publicado: (2020)

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

PB1992: PROTEOMIC ANALYSIS REVEALS AUTOPHAGY INHIBITION IN MYELODYSPLASTIC SYNDROMES
por: Tsekoura, Georgia, et al.
Publicado: (2023)

Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia
por: Saulep-Easton, Damien, et al.
Publicado: (2014)

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis
por: Papageorgiou, Sotirios G., et al.
Publicado: (2017)

Docosahexaenoic Acid Induces Apoptosis in Primary Chronic Lymphocytic Leukemia Cells
por: Guièze, Romain, et al.
Publicado: (2015)

Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
por: Podhorecka, Monika, et al.
Publicado: (2010)

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia
por: Herriott, Ashleigh, et al.
Publicado: (2015)

Chronic Lymphocytic Leukemia
por: Vaisitti, Tiziana, et al.
Publicado: (2020)

Chronic lymphocytic leukemia
por: Rossi, Davide
Publicado: (2018)

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia
por: Villuendas Vázquez, Òscar, et al.
Publicado: (2020)

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
por: Gil-Kulik, Paulina, et al.
Publicado: (2020)

PARP inhibitor re-sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis
por: Wu, Jie, et al.
Publicado: (2019)

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
por: Rodrigues, Celso Arrais, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o1n7iol4p6ujftpjgirak8ohe7